Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia.

MLA

Goshua, George, et al. “Cost-Effectiveness of Second-Line Therapies in Adults with Chronic Immune Thrombocytopenia.” American Journal of Hematology, vol. 98, no. 1, Jan. 2023, pp. 122–30. EBSCOhost, https://doi.org/10.1002/ajh.26497.

APA

Goshua, G., Sinha, P., Kunst, N., Pischel, L., Lee, A. I., & Cuker, A. (2023). Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia. American Journal of Hematology, 98(1), 122–130. https://doi.org/10.1002/ajh.26497

Chicago

Goshua, George, Pranay Sinha, Natalia Kunst, Lauren Pischel, Alfred Ian Lee, and Adam Cuker. 2023. “Cost-Effectiveness of Second-Line Therapies in Adults with Chronic Immune Thrombocytopenia.” American Journal of Hematology 98 (1): 122–30. doi:10.1002/ajh.26497.